Navigation Links
FASEB announces the 2011 Summer Research Conference series: Registration is now open
Date:2/17/2011

Bethesda, MD - Since 1982, the FASEB SRC's have offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.

FASEB has announced 37 SRCs planned for the summer of 2011. Series topics include:

  • Microbial Polysaccharides of Medical, Agricultural, & Industrial Importance
  • Regulation & Function of Small GTPases
  • Proteases in Hemostasis & Vascular Biology
  • From Unfolded Proteins in the Endoplasmic Reticulum to Disease
  • The Molecular & Cellular Origins & the Biomedical Consequences of Protein Aggregation
  • Ion Channel Regulation
  • Biology & Chemistry of Vision
  • Mechanism & Regulation of Procaryotic Transcription
  • Signal Transduction in the Immune System
  • Molecular, Structural & Clinical Aspects of Vitamin K & Vitamin K Dependent Proteins
  • Polycystic Kidney Disease: From Bench to Bedside
  • Melatonin Receptors: Actions & Therapeutics
  • Histone Deacetylases & Reversible Acetylation in Signaling & Disease
  • Nutritional Immunology: Role in Health & Disease
  • Autoimmunity
  • Ciliate Molecular Biology
  • Molecular Mechanisms of Immune Cell Development & Function
  • Dynamic Regulation of Membrane-Based Processes by Tetraspanins & Other Scaffold Proteins
  • Protein Kinases & Protein Phosphorylation
  • Mitochondrial Assembly & Dynamics in Health, Disease & Aging
  • Probiotics, Intestinal Microbiota & the Host: Physiological & Clinical Implications
  • Protein Lipidation, Signaling, & Membrane Domains
  • Microbial Pathogenesis: Mechanisms of Infectious Disease
  • Genetic Recombination & Genome Rearrangements
  • Translational Neuroimmunology: From Mechanisms to Therapeutics
  • Hematopoietic Malignancies
  • Epigenetics, Chromatin & Transcription
  • Helicases & Nucleic Acid Translocases: Stucture, Mechanism, Function, & Roles in Human Diseases
  • Intracellular RNA Transport & Localized Translation (An EMBO, FASEB sponsored conference)
  • Mobile DNA in Mammalian Genomes
  • Nutrient Control of Metabolism & Cell Signaling
  • Lysophospholipid Mediators in Health & Disease
  • Glucose Transporters, Signaling, & Diabetes
  • Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation & Cancer
  • The TGF- Superfamily: Signaling in Development & Diseases
  • NAD Metabolism & Signaling
  • Transcriptional Elongation in Health & Disease

And new in 2011, FASEB has created individual event pages on Facebook and LinkedIn to help facilitate online collaboration prior to the meeting and beyond. This way, attendees can continue intimate discussions on these specialized topics even after the conference has ended. A listing of these event pages can be found at www.FASEB.org/SRC.


'/>"/>

Contact: Julie Levin
SRC@FASEB.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
2. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
3. FASEB alert generates messages urging Congress to provide billion dollar increase for NIH
4. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
5. NIAID announces 25 new awards to develop radiation countermeasures
6. Aware Announces Q3 2008 Earnings Conference Call
7. Governor Doyle announces historic genomic research collaboration
8. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
9. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
10. Parkinsons Disease Foundation announces award of $150,000
11. Jefferson Department of Surgery announces new pancreas tumor registry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
(Date:10/9/2017)... Phoenix, Arizona (PRWEB) , ... October 09, 2017 ... ... of Kindred, a four-tiered line of medical marijuana products targeting the needs of ... production and packaging of Kindred takes place in Phoenix, Arizona. , As operators ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available ... bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, supplementing ...
(Date:10/6/2017)... ... 2017 , ... On Tuesday, October 24th, ABC² (Accelerate Brain ... adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. Brian ... to the public, but registration is required. , WHAT: ABC² Brain Cancer ...
Breaking Biology Technology: